Issue link: http://osercommunicationsgroup.uberflip.com/i/310749
C h a i n D ru g s to re D a i l y M o n d a y, A p ri l 2 8 , 2 0 1 4 4 SUN & SKIN CARE RESEARCH: WHAT'S NEW IN 2014 Embracing the belief that sun care is skin care, Sun & Skin Care Research, LLC (SSCR) is moving into the skin care seg- ment with its Ocean Potion brand. For 2014, Ocean Potion is introducing two new broad spectrum anti-aging formula- tions for daily use: Ocean Potion Protect & Renew Face reduces the appearance of fine lines and wrinkles with a patented collagen-producing peptide and Ocean Potion Protect & Renew Body targets age spots, improving the appearance of skin and brightening skin tone. The brand is also debuting a clear sunscreen formulation: patent-pending Ocean Potion IntelliSeal Technology, which won't turn white, like other sun- screens, when sprayed on wet skin. IntelliSeal is available in two new sport formulations. These innovations, as well as a new Ocean Potion logo and completely redesigned packaging, all celebrate the brand's 25th anniversary. The logo and packaging of the iconic sun care brand has been redesigned with a modern, clean and vibrant look that is color-coded by use: yellow for general protection, blue for sport and green for kids. The evolu- tion of the brand's wave logo plus its refreshed color palette reflect all the warmth and vitality of the sunshine state. Ocean Potion is Florida tested and approved to protect and nourish skin wherever the sun shines. Treasured for its memorable orange-cream fragrance, Ocean Potion is the "Scent of Sunshine." Meanwhile, SSCR's famed BullFrog brand is redefining the meaning of "After Sun" with the introduction of BullFrog Mosquito Coast Insect Repellent with GREENSTONE LLC FOCUSED ON PROVIDING GREAT CUSTOMER SERVICE An interview with Jim Cannon, General Manager, Greenstone LLC. CDD: Tell our readers about your com- pany. What's your main line of business? JC: Greenstone is a wholly-owned sub- sidiary of Pfizer Inc. The business was launched in 1993 as an authorized gener- ics part of The Upjohn Company, and was intended to be a short-term commer- cial strategy. Our first product, launched on June 15, 1993, was an authorized generic of the antibiotic clindamycin top- ical solution and is still sold today. Since that time, according to an IMS Health report from 2013 based on unbranded generics sales, Greenstone has become a top-10 generics company in the United States with a broad portfolio of 55 medi- cines with 195 SKUs. CDD: What would you say makes your company unique? JC: What makes us unique is our team of people, our products and our cus- tomer-centric approach. We have a very dedicated, talented and experienced team that has successfully established our presence as a major player in the generics industry. To keep pace with the evolving needs of our customers, we seek to expand as a 'hybrid' generic business model based on our core authorized generics business. This includes the distribution of generics of off-patent Pfizer brand NDAs and expanding into in-licensed authorized generics and key ANDA products, enabling us to effectively identify and leverage high margin molecules, as well Continued on Page 23 Continued on Page 23 AN INDEPENDENT PUBLICATION NOT AFFILIATED WITH NACDS Lee M. Oser CEO and Editor-in-Chief Kim Forrester Paul Harris Jeff Rosano Associate Publisher Lorrie Baumann Editorial Director JoEllen Lowry Jeanie Catron Jeff Calvello Associate Editors Yasmine Brown Vicky Glover Graphic Designers Mandy Feld Ruth Haltiwanger Customer Service Managers Jules Denton Account Manager Enrico Cecchi European Sales Chain Drugstore Daily is published by Oser Communications Group ©2014. All rights reserved. Executive and editorial offices at: 1877 N. Kolb Road, Tucson, AZ 85715 520-721-1300/Fax: 520-721-6300 www.oser.com European offices located at Lungarno Benvenuto Cellini, 11, 50125 Florence, Italy.